Literature DB >> 26470014

Sequential activation of microglia and astrocyte cytokine expression precedes increased Iba-1 or GFAP immunoreactivity following systemic immune challenge.

Diana M Norden1, Paige J Trojanowski1, Emmanuel Villanueva1, Elisa Navarro1, Jonathan P Godbout1,2.   

Abstract

Activation of the peripheral immune system elicits a coordinated response from the central nervous system. Key to this immune to brain communication is that glia, microglia, and astrocytes, interpret and propagate inflammatory signals in the brain that influence physiological and behavioral responses. One issue in glial biology is that morphological analysis alone is used to report on glial activation state. Therefore, our objective was to compare behavioral responses after in vivo immune (lipopolysaccharide, LPS) challenge to glial specific mRNA and morphological profiles. Here, LPS challenge induced an immediate but transient sickness response with decreased locomotion and social interaction. Corresponding with active sickness behavior (2-12 h), inflammatory cytokine mRNA expression was elevated in enriched microglia and astrocytes. Although proinflammatory cytokine expression in microglia peaked 2-4 h after LPS, astrocyte cytokine, and chemokine induction was delayed and peaked at 12 h. Morphological alterations in microglia (Iba-1(+)) and astrocytes (GFAP(+)), however, were undetected during this 2-12 h timeframe. Increased Iba-1 immunoreactivity and de-ramified microglia were evident 24 and 48 h after LPS but corresponded to the resolution phase of activation. Morphological alterations in astrocytes were undetected after LPS. Additionally, glial cytokine expression did not correlate with morphology after four repeated LPS injections. In fact, repeated LPS challenge was associated with immune and behavioral tolerance and a less inflammatory microglial profile compared with acute LPS challenge. Overall, induction of glial cytokine expression was sequential, aligned with active sickness behavior, and preceded increased Iba-1 or GFAP immunoreactivity after LPS challenge.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  astrocytes; lipopolysaccharide; microglia; neuroinflammation; sickness behavior

Mesh:

Substances:

Year:  2015        PMID: 26470014      PMCID: PMC4707977          DOI: 10.1002/glia.22930

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  71 in total

1.  Loss of interleukin receptor-associated kinase 4 signaling suppresses amyloid pathology and alters microglial phenotype in a mouse model of Alzheimer's disease.

Authors:  Brent Cameron; Wayne Tse; Raza Lamb; Xiaoxia Li; Bruce T Lamb; Gary E Landreth
Journal:  J Neurosci       Date:  2012-10-24       Impact factor: 6.167

2.  Peripheral innate immune challenge exaggerated microglia activation, increased the number of inflammatory CNS macrophages, and prolonged social withdrawal in socially defeated mice.

Authors:  Eric S Wohleb; Ashley M Fenn; Ann M Pacenta; Nicole D Powell; John F Sheridan; Jonathan P Godbout
Journal:  Psychoneuroendocrinology       Date:  2012-03-02       Impact factor: 4.905

3.  Differential activation of astrocytes by innate and adaptive immune stimuli.

Authors:  Pamela A Carpentier; Wendy Smith Begolka; Julie K Olson; Adam Elhofy; William J Karpus; Stephen D Miller
Journal:  Glia       Date:  2005-02       Impact factor: 7.452

Review 4.  Microglia and neurodegeneration: the role of systemic inflammation.

Authors:  Colm Cunningham
Journal:  Glia       Date:  2012-06-06       Impact factor: 7.452

Review 5.  Review: microglia of the aged brain: primed to be activated and resistant to regulation.

Authors:  D M Norden; J P Godbout
Journal:  Neuropathol Appl Neurobiol       Date:  2013-02       Impact factor: 8.090

6.  Morphological and genetic activation of microglia after diffuse traumatic brain injury in the rat.

Authors:  T Cao; T C Thomas; J M Ziebell; J R Pauly; J Lifshitz
Journal:  Neuroscience       Date:  2012-09-06       Impact factor: 3.590

7.  The bacterial endotoxin lipopolysaccharide has the ability to target the brain in upregulating its membrane CD14 receptor within specific cellular populations.

Authors:  S Lacroix; D Feinstein; S Rivest
Journal:  Brain Pathol       Date:  1998-10       Impact factor: 6.508

8.  Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4.

Authors:  Zhihong Chen; Walid Jalabi; Karl B Shpargel; Kenneth T Farabaugh; Ranjan Dutta; Xinghua Yin; Grahame J Kidd; Cornelia C Bergmann; Stephen A Stohlman; Bruce D Trapp
Journal:  J Neurosci       Date:  2012-08-22       Impact factor: 6.167

9.  Interleukin-1beta induces a reactive astroglial phenotype via deactivation of the Rho GTPase-Rock axis.

Authors:  Gareth R John; Lanfen Chen; Mark A Rivieccio; Carmen V Melendez-Vasquez; Adam Hartley; Celia F Brosnan
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

10.  Long-term impact of systemic bacterial infection on the cerebral vasculature and microglia.

Authors:  Ursula Püntener; Steven G Booth; V Hugh Perry; Jessica L Teeling
Journal:  J Neuroinflammation       Date:  2012-06-27       Impact factor: 8.322

View more
  156 in total

1.  Huntington's disease brain-derived small RNAs recapitulate associated neuropathology in mice.

Authors:  Jordi Creus-Muncunill; Anna Guisado-Corcoll; Veronica Venturi; Lorena Pantano; Georgia Escaramís; Marta García de Herreros; Maria Solaguren-Beascoa; Ana Gámez-Valero; Cristina Navarrete; Mercè Masana; Franc Llorens; Daniela Diaz-Lucena; Esther Pérez-Navarro; Eulàlia Martí
Journal:  Acta Neuropathol       Date:  2021-02-06       Impact factor: 17.088

2.  Interleukin-1 causes CNS inflammatory cytokine expression via endothelia-microglia bi-cellular signaling.

Authors:  Ling Zhu; Xiaoyu Liu; Daniel P Nemeth; Damon J DiSabato; Kristina G Witcher; Daniel B Mckim; Braedan Oliver; Xi Le; Gowthami Gorantla; Olimpia Berdysz; Jiaoni Li; Aishwarya D Ramani; Zhibiao Chen; Dongcheng Wu; Jonathan P Godbout; Ning Quan
Journal:  Brain Behav Immun       Date:  2019-06-19       Impact factor: 7.217

3.  Acyl-CoA synthetase 6 enriches the neuroprotective omega-3 fatty acid DHA in the brain.

Authors:  Regina F Fernandez; Sora Q Kim; Yingwei Zhao; Rachel M Foguth; Marcus M Weera; Jessica L Counihan; Daniel K Nomura; Julia A Chester; Jason R Cannon; Jessica M Ellis
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-06       Impact factor: 11.205

4.  Interleukin-1 receptor antagonist ameliorates the pain hypersensitivity, spinal inflammation and oxidative stress induced by systemic lipopolysaccharide in neonatal rats.

Authors:  Cheng-Ta Hsieh; Yih-Jing Lee; Jonathan W Lee; Silu Lu; Michelle A Tucci; Xiaoli Dai; Norma Beatriz Ojeda; Hyun Joon Lee; Lir-Wan Fan; Lu-Tai Tien
Journal:  Neurochem Int       Date:  2020-01-25       Impact factor: 3.921

Review 5.  Role of astroglia in diet-induced central neuroplasticity.

Authors:  Courtney Clyburn; Kirsteen N Browning
Journal:  J Neurophysiol       Date:  2019-01-30       Impact factor: 2.714

6.  Intranasal delivery of dexamethasone efficiently controls LPS-induced murine neuroinflammation.

Authors:  G Meneses; G Gevorkian; A Florentino; M A Bautista; A Espinosa; G Acero; G Díaz; A Fleury; I N Pérez Osorio; A Del Rey; G Fragoso; E Sciutto; H Besedovsky
Journal:  Clin Exp Immunol       Date:  2017-09-07       Impact factor: 4.330

7.  Sex differences in microglial phagocytosis in the neonatal hippocampus.

Authors:  Lars H Nelson; Spencer Warden; Kathryn M Lenz
Journal:  Brain Behav Immun       Date:  2017-03-22       Impact factor: 7.217

Review 8.  Neuroimmune Response in Ischemic Preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

Review 9.  Astrocytes: Heterogeneous and Dynamic Phenotypes in Neurodegeneration and Innate Immunity.

Authors:  Colm Cunningham; Aisling Dunne; Ana Belen Lopez-Rodriguez
Journal:  Neuroscientist       Date:  2018-11-17       Impact factor: 7.519

10.  Correction to: Neuroimmune Response in Ischemic Preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.